Literature DB >> 20135135

Clinicopathological and immunohistochemical analysis of sclerosing stromal tumours of the ovary.

Osman Zekioglu1, N Ozdemir, C Terek, A Ozsaran, Y Dikmen.   

Abstract

INTRODUCTION: Sclerosing stromal tumours (SST) of the ovary are rare, benign tumours. SSTs are usually hormone inactive and tend to occur in the second and third decades of life. The most common clinical symptom is menstrual irregularity.
MATERIALS AND METHODS: Fourteen women diagnosed with SST of the ovary were included in this study. Tumour samples were collected, embedded in paraffin and stained with haematoxylin and eosin, periodic acid-Schiff (PAS), and PAS with digestion, as well as immunohistochemically for vimentin, smooth muscle actin, desmin, CD 99, inhibin-α and the oestrogen and progesterone receptor.
RESULTS: The age of the patients ranged from 16 to 54 years (mean age 25.2 years). The tumours ranged in size from 6 to 21 cm (mean 10.5 cm). Macroscopically, eight tumours were solid and six were solid and cystic. All SSTs were well circumscribed with pseudolobule formation. Spindle-shaped fibroblast-like cells and vacuolated theca-like cells were prominent. Blood vessels exhibited a hemangiopericytomatous pattern and boomerang-like features. Immunohistochemical results were as follows: vimentin, 14/14 cases positive; smooth muscle actin, 14/14 cases positive; desmin, 14/14 cases positive; CD 99, 4/14 cases positive; inhibin-α, 14/14 cases positive; oestrogen receptor, 0/14 cases positive; progesterone receptor, 2/14 cases positive.
CONCLUSIONS: The characteristic histopathological features we observed in our study are usually adequate for the diagnosis of SSTs. Although inhibin-α, CD 99 and desmin staining may be a useful and reliable tool for SST diagnosis in problematic cases, an immunohistochemical panel will not discriminate from other tumours in the sex cord-stromal group.

Entities:  

Mesh:

Year:  2010        PMID: 20135135     DOI: 10.1007/s00404-010-1373-9

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  6 in total

1.  Different Presentations of Five Rare Cases of Sclerosing Stromal Tumor of the Ovary.

Authors:  Mozhdeh Momtahan; Mojgan Akbarzadeh-Jahromi; Fateme Sadat Najib; Niloofar Namazi
Journal:  Indian J Surg Oncol       Date:  2018-05-19

2.  Sclerosing stromal tumor of the ovary treated with 2-incision total laparoscopic cystectomy.

Authors:  Shigenori Furukawa; Kiyoshi Kanno; Manabu Kojima; Miki Ohara; Shu Soeda; Satoshi Suzuki; Takafumi Watanabe; Hiroshi Nishiyama; Tsuyoshi Honda; Keiya Fujimori
Journal:  Int J Surg Case Rep       Date:  2015-02-16

3.  Sclerosing Sromal Tumor of the Ovary in Postmenopausal Women: A Report of Two Cases.

Authors:  Chae Min Lee; Soyi Lim; Hyun Yi Cho; Ji-Sung Lee; Jin Woo Shin
Journal:  J Menopausal Med       Date:  2015-08-28

4.  Sclerosing stromal tumour of the ovary: A case report and the review of literature.

Authors:  Ozhan Ozdemir; Mustafa Erkan Sarı; Ertuğrul Sen; Aslıhan Kurt; Ayşe Burce Ileri; Cemal Reşat Atalay
Journal:  Niger Med J       Date:  2014-09

5.  Sclerosing stromal tumor of the ovary: a case series and review of literature.

Authors:  Christof Mittermair; Teresa Margarida Cunha; Romana Urbas; Horst Koch; Rosemarie Forstner
Journal:  BJR Case Rep       Date:  2021-12-03

6.  Clinicopathological spectrum of ovarian sex cord-stromal tumors; 20 years' retrospective study in a developing country.

Authors:  Saroona Haroon; Aleena Zia; Romana Idrees; Aisha Memon; Saira Fatima; Naila Kayani
Journal:  J Ovarian Res       Date:  2013-12-05       Impact factor: 4.234

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.